ERVW-1 gene polymorphisms related to preeclampsia

Bratislava Medical Journal

Volumn 117, Issue 6, 2016, Pages 340-344

  Priscakova, P ^a   Konkolova, J ^a   Petrovic, R ^a   Lipov, J ^b   Minarik, G ^c   Bohmer, D ^a   Repiska, V ^a   Gbelcova, H ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^b INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^c Medirex Group Academy   (Slovakia)

Author keywords

Diagnostics; DNA polymorphisms; ERVW 1; Preeclampsia; Syncytin 1

Indexed keywords

PLACENTA PROTEIN; SYNCYTIN; VIRUS ENVELOPE PROTEIN;

CASE CONTROL STUDY; FEMALE; FETUS DEATH; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; PREECLAMPSIA; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVAKIA;

ABORTED FETUS; CASE-CONTROL STUDIES; FEMALE; GENE PRODUCTS, ENV; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; SLOVAKIA;

EID: 85014832792     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2016_067     Document Type: Article

References (34)

1. Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010; 28: 1349-1355.
2. Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J. Pre-eclampsia-pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011; 7: 467-474.
3. Roberts JM, Bell MJ. If we know so much about preeclampsia, why haven't we cured the desease? J Reprod Immunol 2013; 99: 1-9.
4. Knerr I, Beinder E, Rascher W. Syncytin, a novel human endogenous retroviral gene in human placenta: Evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J of Obstet Gynecol 2002; 186: 210-213.
5. Cnossen JS, Van der Post JAM., Mol BWJ, Khan KS, Meads CA, Riet G. Prediction of pre-clampsia: a protocol for systematic reviews of test accuracy. BMC Pregnancy and Childbirth 2006; 6: 1-8.
6. Hammerova L, Chabada J, Drobny J, Batorova A. Lonfitudinal evaluation of markers of hemostasis in pregnancy. Bratisl Lek Listy 2014; 115 (3): 140-144.
7. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy Childbirth 2009; 9: 1-15.
8. van Pampus MG, Aarnoudse JG. Long-Term Outcomes after Preeclampsia. Clinic Obstet Gynecol 2005; 48: 489-494.
9. Kaufman P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69: 1-7.
10. Bujold E, Roberge S, Lacasse Y et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414.
11. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104: 1367-1391.
12. Giguère Y, Charland M, Bujold E et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem. 2010; 56 (3): 361-375.
13. Blond J, Lavillette D, Cheynet V et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 2000; 74: 3321-3329.
14. Mi S, Lee X, Li X et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000; 403: 785-789.
15. Malassiné A, Handschuh K, Tsatsaris V et al. Expression of HERVW Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta 2005; 26: 556-562.
16. Muir A, Lever AML, Moffett A. Human endogenous retrovirus-W envelope (syncytin) is expressed in both villous and extravillous trophoblast populations. J Gen Virol 2006; 87: 2067-2071.
17. Handwerger S. New insights into the regulation of human cytotrophoblast cell differentiation. Mol Cell Endocrinol 2010; 323: 94-104.
18. Blond J, Besème F, Duret L et al. Molecular Characterization and Placental Expression of HERV-W, a New Human Endogenous Retrovirus Family. J of Virol 1999; 73: 1175-1185.
19. Frendo J, Olivier D, Cheynet V et al. Direct Involment of HERV-W Env Glycoprotein in Human Trophoblast Cell Fusion and Diffrerentiation. Mol Cell Biol 2003; 23: 3566-3574.
20. Huang Q, Chen H, Li J et al. Epigenetic and non-epigenetic regulation of syncytin-1 expression in human placenta and cancer tissues. Cell Signal 2014; 26: 648-656.
21. Lee X, Keith JC Jr., Stumm N et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001; 22: 808-812.
22. Vargas A, Toufaily Ch, LeBellego F, Rassart E, Lafond J, Barbeau B. Reduced Expression of Both Syncytin 1 and Syncytin 2 Correlates With Severity of Preeclampsia. Reprod Sci 2011; 18: 1085-1091.
23. Prudhomme S, Oriol G, Mallet F. A Retroviral Promoter and a Cellular Enhancer Define a Bipartite Element Which Controls env ERVWE1 Placental Expression. J Virol 2004; 78 (22): 12157-12168.
24. Cheng YH, Richardson BD, Hubert MA, Handwerger S. Isolation and characterization of the human syncytin gene promoter. Biol Reprod 2004; 70: 694-701.
25. Matoušková M, Blažková J, Pajer P, Pavlícek A, Hejnar J. CpG methylation suppresses transcriptional activity of human syncytin-1 in nonplacental tissues. Exp Cell Res 2006; 312: 1011-1020.
26. Gimenez J, Montgiraud C, Oriol G et al. Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues. DNA Res 2009; 16: 195-211.
27. Muschol-Steinmetz C, Friemel A, Kreis N-N, Reinhard J, Yuan J. Fumction of Survivin in Trophoblastic Cells of the Placenta. PLoS ONE 2013; 8(9): e73337. doi:10.1371/journal.pone.0073337.
28. Adamkov M, Halasova E, Kajo K, Machalekova K, Vybohova D, Varga I, Rajcany J. Survivin: a promising biomarker in breast carcinoma. Neoplasma 2010; 57 (6): 572-577.
29. Krajciova L, Deziova L, Petrovic R, Luha J, Turcani P, Chandoga J. Frequencies of polymorphisms in CYP2C9 and VKORC1 genes influencing warfarin metabolism in Slovak population: implication for clinical practice. Bratisl Lek Listy 2014; 115 (9): 563-568.
30. Redman CW, Sargent IL. Latest Advances in Understanding Preeclampsia. Science 2005; 308: 1592-1594.
31. Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med 2004; 200: 951-955.
32. Yu H, Liu T, Zhao Z et al. Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytín-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. Oncogene 2014; 33: 3947-3958.
33. Langbein M, Strick R, Strissel PL et al. Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev 2008; 75: 175-183.
34. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30: 532-537.